Gilead shares jump on hepatits C drug results

Shares of Gilead Sciences jump after the biotechnology firm announces positive results from a hepatitis C treatment
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.